Low-dose cytosine arabinoside in patients with acute myeloblastic leukemia and myelodysplastic syndrome.
D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D012074:Remission Induction; D013997:Time Factors
D003561:Cytarabine